Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse (Q76380658)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

title

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

main subject

lymphoblastic leukemia

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

author name string

Coustan-Smith E

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Gajjar A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Hijiya N

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Razzouk BI

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Ribeiro RC

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Rivera GK

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Sandlund JT

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Andreansky M

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Hancock ML

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Pui CH

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Campana D

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

499-504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14981525%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403283

24 November 2019

exact match

0 references

cites work

Childhood acute lymphoblastic leukaemia--current status and future perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Relapsed lymphoblastic leukaemia in children: a continuing challenge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Treatment of relapsing acute lymphoblastic leukemia in childhood. III. Experiences with 54 first bone marrow, nine isolated testicular, and eight isolated central nervous system relapses observed 1985-1989.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: a 10-year follow-up study. Italian Association of Pediatric Hematology-Oncology (AIEOP)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children's Cancer Group (CCG-1884)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group Experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Outcome after relapse in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

New definition of remission in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Determination of minimal residual disease in leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Pharmacokinetics and pharmacodynamics of oral etoposide in children with relapsed or refractory acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

'Ponte di Legno' Working Group--report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April - 1 May 2002.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403283

7 January 2021